No change to India’s two-dose schedule for AstraZeneca vaccine – govt adviser By Reuters

NEW DELHI (Reuters) – India will stick to its schedule of giving two doses of AstraZeneca (NASDAQ:AZN)’s vaccine, a senior government adviser said on Tuesday.

“India’s Covishield schedule is of two doses… there is no change and Covaxin is also for two doses,” government advisor V K Paul told reporters at a news conference.

Mixing of vaccines is not a protocol and research is currently being conducted on this, he added.